Sun Pharmaceutical Industries Limited announced that the meeting of the board of directors of the company held on February 14, 2017 approved the appointment of Mr. Kalyanasundaram Subramanian as an additional director and wholetime director of the company with immediate effect. On February 13, 2017, Kal has also been appointed as the CEO & Whole-time Director of Sun Pharma Laboratories Limited. In January 2017, Kal moved back to India to manage India and EM regions of Sun. In 2012, Kal moved to USA to Taro Pharmaceutical Industries Ltd., to assume responsibility of Taro's operations in North America. In 2010, Kal joined Sun as the CEO and Director to manage India and Emerging Markets.